Toggle navigation
Home
Search
Services
Blog
Contact
About
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff
Immunopharmaceutics, Inc., San Diego, CA, United States
Search 3 grants from Wolff Manfred
Search grants from Immunopharmaceutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Tolerance defenses in host-microbiota interactions
Mechanism of antifungal action of Pichia proteins
Development of the Gag/Lysyl tRNA synthetase interaction as a target for anti-HIV
Novel Lymphocyte Integrins
Polynuclear Anticancer Antibiotics: Selected Syntheses
Recently added grants:
Real time fine needle assessment of architectural heterogeneity in prostate cancer
Chemistry and Biology of Alkyl Phosphotriester Lesions
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
Novel role of CD73 in c-Met-mediated immune escape in renal cell carcinoma
Mechanisms of BAP1 activity in human cancer development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43MH030021-002
Application #
3667508
Study Section
Project Start
1993-09-01
Project End
1994-04-15
Budget Start
1994-03-01
Budget End
1994-04-15
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Immunopharmaceutics, Inc.
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92127
Related projects
NIH 1994
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Manfred, Wolff / Immunopharmaceutics, Inc.
NIH 1993
N43 MH
Design/Synthesis of Oral Galanin Agonists/Antagonists
Wolff, Manfred E. / Immunopharmaceutics, Inc.
Comments
Be the first to comment on Wolff Manfred's grant